Status:

COMPLETED

Episodic Future Thinking to Improve Management of Type 2 Diabetes: Remote Delivery and Outcomes Assessment

Lead Sponsor:

Virginia Polytechnic Institute and State University

Collaborating Sponsors:

Carilion Clinic

University at Buffalo

Conditions:

Type 2 Diabetes

Overweight and Obesity

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Successful management of type 2 diabetes (T2D) requires adherence to a dietary, physical activity, and medication plan agreed upon between a patient and their healthcare providers. The lifestyle chang...

Detailed Description

In a 24-week trial, 120 participants from both urban (n = 60) and rural (n = 60) areas will be assigned receive either remotely delivered episodic future thinking or a control condition. Participants ...

Eligibility Criteria

Inclusion

  • HbA1c greater than or equal to 7.7%
  • from urban or rural area
  • body mass index greater than or equal to 30

Exclusion

  • gestational diabetes
  • pregnancy or lactating
  • not ambulatory
  • intellectual impairment
  • unmanaged comorbid psychiatric diagnosis (including eating disorders)

Key Trial Info

Start Date :

July 20 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 15 2025

Estimated Enrollment :

137 Patients enrolled

Trial Details

Trial ID

NCT05280925

Start Date

July 20 2022

End Date

April 15 2025

Last Update

June 26 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Fralin Biomedical Research Institute at VTC

Roanoke, Virginia, United States, 24016

Episodic Future Thinking to Improve Management of Type 2 Diabetes: Remote Delivery and Outcomes Assessment | DecenTrialz